disease stage, histology (embryonal versus alveolar), the patient's age, and postsurgery disease [10] .
Rhabdomyosarcoma is rarely cured by one modality alone, so multimodal treatment is indicated. This consists of chemotherapy and either surgery or radiotherapy, the decision being individualized to the tumor site and stage. The IRS-IV study protocol resulted in 5-year survival rates of 97% in embryonal nonorbital, nonparameningeal head and neck cases, and 67% in the alveolar cases [11] . Surgical excision is recommended for localized disease [12] , as it improves survival and, if complete, avoids the need for radiotherapy, which is associated with a high risk of morbidity in children (facial growth retardation, second neoplasm). In large or extensive rhabdomyosarcomas of the head and neck in which the morbidity of surgical resection is excessive and/or complete resection unobtainable (e.g. nasaopharynx, paranasal sinuses, and temporal bone), treatment with combination chemoradiotherapy is indicated.
Restaging at least 6 weeks after completion of therapy can include computed tomography (CT), MRI, and fluoro-deoxyglucose PET [10] . For those cases with a high probability of residual disease, postchemoradiotherapy salvage surgery may be recommended by the multidisciplinary team, but the potential for significant morbidity from extensive head and neck resection should be carefully considered. Tumor location may limit the ability to achieve adequate resection margins, and extensive surgical reconstruction may be required. A significant proportion of patients undergoing salvage surgery will die from the disease, so patients and families should be carefully counseled, and they may decline complex and morbid surgical resection in favor of palliation.
Thyroid cancer
Children and adolescents account for 2% of all thyroid cancer, with an annual incidence of 2.4 per 100 000 [13] . Sporadic differentiated thyroid cancers (papillary and mixed papillary-follicular) are the most common endocrine malignancies in children, and a female preponderance is most pronounced in postpubertal children [14] .
Pure follicular carcinoma is less common, and anaplastic and undifferentiated forms are extremely rare. Medullary thyroid carcinoma (MTC) must be considered in children with multiple endocrine neoplasia (MEN) types IIA and IIB. Radiation exposure has been identified as a risk factor for childhood thyroid cancer, as recognized following the Chernobyl nuclear accident [15] . Risk is also increased after treatment of lymphoma and leukemia, particularly for children treated before 10 years of age and in those receiving radiation doses up to 30 Gy [16] . Recent work has suggested that iodine deficiency could increase incidence, reduce latency, and influence tumor aggressiveness of radiation-induced thyroid carcinogenesis [17 ] .
Thyroid cancer should be suspected when a solitary thyroid nodule is identified in children and adolescents, with 20% estimated to represent malignancy compared with 5% in adults [18 ] . Initial investigation should include measurement of serum thyroid-stimulating hormone (TSH), calcitonin (for diagnosis of MTC), and a neck ultrasound scan. Ultrasound features suggestive of malignancy include indistinct margins, microcalcifications, and variable echogenicity. As in adults, fine needle aspiration (FNA) may be useful for distinguishing benign and malignant nodules, but data are limited in children. When the aspirate demonstrates malignancy, surgery is recommended. When the cytology is indeterminate or inadequate, options include repeating ultrasound-guided FNA within 3-6 months, or proceeding to surgery, after discussion of the risk-to-benefit ratio. In young children at higher risk of malignancy (under 10 years of age, previous radiation exposure, family history of thyroid cancer), prompt surgical treatment is advisable and FNA is not required.
The surgical approach for children remains controversial due to the balance between improved disease eradication and possibly increased risk from total thyroidectomy versus increased chance of residual or recurrent disease with hemithyroidectomy. Newer techniques for thyroidectomy such as microbipolar dissection minimize potential risks of nerve injury and hypocalcemia. Additionally, at least 40% of differentiated thyroid cancer in children is 472 Pediatric otolaryngology Size: a, greatest dimension less than 5 cm; b, greatest dimension more than 5 cm. Tumor invasiveness (T stage): T1, confined to anatomic site of origin; T2, extension and/or fixation to surrounding tissue. Regional lymph nodes (N stage): N0, regional lymph nodes not clinically involved; N1, regional lymph nodes clinically involved; Nx, status of regional lymph nodes unknown. Metastasis (M stage): M0, no distant metastasis; M1, distant metastasis present. IRS, Intergroup Rhabdomyosarcoma Study. Adapted from [9] .
multifocal, and total thyroidectomy allows for postoperative administration of radioactive iodine and the use of serial thyroglobulin measurement for surveillance. Hence, a reasonable approach would be hemithyroidectomy in the suspicion of malignancy, with total thryoidectomy (initial or completion) in the presence of definitive cancer diagnosis. Central compartment lymph node dissection for palpable or ultrasound-detected nodes is recommended at the time of total or completion thyroidectomy.
In children with MEN types IIA and IIB and RET protooncogene mutation, MTC is the most common cause of death, as it spreads early and is relatively resistant to chemoradiotherapy. The most effective management is prophylactic thyroidectomy before MTC presentation, but timing of surgery is controversial. MTC occurs at different ages as influenced by the genotype and has been reported as early as 17 months in a germline mutation carrier [19] . A pragmatic approach may be individualized 'codon-directed' timing, in which prophylactic thyroidectomy timing is dictated by the specific genotype and performed before the earliest reported age of MTC diagnosis for the specific RET mutation codon [20, 21] . Alternatively, universal early total thyroidectomy can be advocated to reduce anxiety and the risk of early presentation.
Salivary gland malignancy
Salivary gland neoplasms are rare in childhood, but after exclusion of vascular lesions, approximately half are malignant [22] . Malignant lesions are more common in older children, and overall usually have a good prognosis. Five-year survival is similar to adults (over 90%) [23] . The majority of salivary malignancies occur in the parotid gland, in which the most common lesion is mucoepidermoid carcinoma, and, in contrast to adults, most submandibular gland and minor salivary gland tumors are benign [22] . Mucoepidermoid carcinoma is also the commonest radiation-induced salivary gland tumor in children [24] . Other malignant lesions described include acinic cell carcinoma, adenoid cystic carcinoma, and adenocarcinoma. Newer techniques such as microbipolar dissection and extracapsular dissection with nerve monitoring allow partial parotidectomy for the resection of malignant lesions, preserving full nerve function.
Surveillance is dependent on tumor resection margins, tumor subtype, and ease of clinical assessment by palpation. A baseline MRI scan may be indicated once surgical healing is complete, with follow-up MRI scanning as in adults. Regular chest radiographs may be required for cases of acinic cell carcinoma. Re-excision is recommended for salivary gland disease recurrence, and radiotherapy should be used only in carefully selected cases of aggressive malignancy in view of the high risk of radiation-related complications in children.
Neuroblastoma
Neuroblastoma is the most common extracranial solid tumor of childhood, but primary head and neck incidence accounts for less than 5% of cases [25] . These tumors arise in the neural crest progenitor cells of the sympathetic nervous system. Those originating from the sympathetic cervical ganglia will arise as a lateral neck mass or retropharyngeal mass. They present with an impingement of head and neck structures such as the jugular foramen cranial nerves, upper aerodigestive structures (causing stridor, dysphagia, or aspiration), or with Horner's syndrome. Metastatic spread from an abdominal or thoracic primary to the orbital soft tissues can also occur and presents with periorbital swelling, ecchymosis, or ophthalmoplegia. Overall survival, with a median follow-up of 4 years, has been estimated as 91%, with no significant difference between cervical and cervicothoracic neuroblastoma [25] .
Diagnostic tests include plain radiography, ultrasound, CT, and MRI. Metastatic evaluation may include bone marrow studies, bone scans, and scintigraphy with 131 I-metaiodobenzylmandelic [metaiodobenzylguanidine (MIBG)] to assess bone disease and response to therapy [26] . Treatment involves surgery in most cases, with adjuvant chemotherapy, and occasionally radiotherapy, depending on the stage of the disease. If localized, primary or secondary head and neck neuroblastoma may be amenable to complete surgical excision, providing a more favorable prognosis. In extensive or metastatic disease, multimodal treatment is individualized to the patient. MIBG has recently shown efficacy in high-risk cases as an induction therapy before surgery [27 ] .
Nasopharyngeal carcinoma
NPC is rare in North America but more common in southern China, Southeast Asia, the Mediterranean basin, and Alaska [28] . In children, the median age of NPC development is 13 years and incidence is higher in males [29] . Factors implicated in the cause and development of NPC include genotype (specific human leukocyte antigen subtypes), environment (such as salted fish high in volatile nitrosamines [28] Treatment of NPC has generally followed guidelines established for adults, with high-dose radiotherapy to the nasopharynx and involved neck lymph nodes. However, childhood NPC is distinguished from adult NPC by its close association with EBV, predominance of type III histology, and high incidence of advancedstage disease, in addition to the significant morbidity of high-dose radiotherapy in childhood [28] . This has led to an increase in trials of adjuvant, neoadjuvant, and concomitant chemotherapy. A recent study [30] employing first-line chemotherapy with or without radiotherapy showed 5-year survival rates of 73%. Extensive surgical resection, such as the maxillary swing procedure, is not applicable to children due to skeletal immaturity, surgical morbidity, and concern about incomplete resection.
Non-Hodgkin's lymphoma
Pediatric non-Hodgkin's lymphoma (NHL) occurs in about 600 new cases annually in the United States, with nearly 25% in children aged less than 10 years [31] . The overall incidence in children and adolescents is approximately 30 per million, with increasing incidence with age and a male predominance [31] . Histological varieties of NHL are divided into low, intermediate, and high grade, and the vast majority presenting in childhood are high grade [32] . About 90% of childhood NHLs are mature B-cell lymphomas [Burkitt (40%) or diffuse large B-cell (10%)], lymphoblastic lymphomas (30%), or anaplastic large cell lymphomas (10%). The remaining 10% consist of the diseases commonly seen in adults such as follicular lymphoma, mucosa-associated lymphoid tissue lymphoma, and mature T-cell lymphoma [33] . Immunodeficient individuals (congenital or acquired) are at an increased risk of NHL, predominantly of the mature B-cell type, and these are associated with EBV.
Childhood NHL presents in the head and neck region in 5-10% of cases, most commonly with asymptomatic cervical lymphadenopathy. Other regions that may be involved include the salivary glands, larynx, sinuses, and orbit. NHL may also manifest in the extranodal lymphoid tissue of Waldeyer's ring, presenting as an asymmetric tonsillar enlargement or mimicking adenoidal hypertrophy. Up to one-fifth of children undergoing routine tonsillectomy may have some degree of coincidental innocent tonsillar asymmetry [34] . Therefore, tonsillectomy may not be indicated by asymmetry alone, without consideration of other factors such as constitutional symptoms (fever, weight loss, and night sweats), a history of rapid unilateral enlargement, or associated cervical lymphadenopathy or hepatosplenomegaly.
Histological subclassification may be challenging, and an open excisional biopsy of lymph nodes is considered the gold standard for diagnostic evaluation. Recently, publications have advocated diagnosing and classifying lymphomas using less invasive techniques, benefiting from image-guided cutting needle biopsies and advances in the use of cytopathological and immunohistochemical techniques with small specimens [35] . These techniques have been very successfully applied to cervical lymphadenopathy in some units [36 ] but remain controversial [37] and may not be applicable to the pediatric population. Biopsy tissue should be sent fresh to the pathologist to facilitate flow cytometry, immunohistochemical staining, electron microscopy, and molecular genetic testing.
The foundation of treatment for pediatric NHL is based on aggressive multiagent chemotherapy directed by the histology and disease stage. The most commonly used agents include CHOP-based regimens (cyclophosphamide, hydroxydaunomycin, vincristine, and prednisone), and some protocols include other agents in more advanced stages of recurrence. Radiotherapy is not routinely used for local NHL treatment but has been used in central nervous system (CNS) prophylaxis, although this may not be helpful in CNS-negative children with an adequate response to induction chemotherapy [38] . The disease-free survival period for pediatric NHL has been improving with the continuously evolving treatment regimes, resulting in long-term survival being achieved in over 80% [33] .
Hodgkin's lymphoma
Pediatric Hodgkin's lymphoma occurs in about 1000 cases annually in the United States, the majority occurring in teenage children [31] . Overall incidence in children and adolescents is about 50 per million, with only 5% of these occurring in children under 10 years old, in whom incidence is significantly lower than NHL [31] . In young children, there is a male predominance, but there are no sex differences after puberty. As in NHL, there is an association between Hodgkin's lymphoma and EBV infection, with many children having evidence of prior exposure, and in-situ hybridization demonstrating Epstein-Barr genomes in the pathognomonic ReedSternberg cell [39] .
Hodgkin's lymphoma is histologically separated into two broad categories: 'classical' Hodgkin's lymphoma (90%), comprising lymphocyte-depleted (rare in children), nodular sclerosing, and mixed cellularity subtypes, and 'lymphocyte-predominant' Hodgkin's lymphoma (10%). Classical Hodgkin's lymphoma is characterized by the presence of CD15 and CD30-positive Reed-Sternberg cells. Lymphocyte-predominant Hodgkin's lymphoma is CD20 positive and has a distinctive phenotype, presenting at an early stage without systemic symptoms, involving localized peripheral lymph nodes, and having a diseasefree survival of over 95% [40] .
Hodgkin's lymphoma most commonly presents in children with asymptomatic cervical and supraclavicular lymphadenopathy, with or without systemic constitutional symptoms (fever, weight loss, and night sweats), which unfavorably affect prognosis [41] . The lymphadenopathy is described as firm, rubbery, and nontender. As in NHL, lymph node biopsy is considered the gold standard for diagnosis of Hodgkin's lymphoma. Treatment for Hodgkin's lymphoma is based on stratification of risk groups determined by histology, stage at presentation, number of involved sites, disease bulk, and the presence or absence of constitutional symptoms. Early lymphocytepredominant Hodgkin's lymphoma can be considered separately and may be treated by radiation alone or sometimes by surgical excision and observation. Low-risk (localized and nonbulky), classical Hodgkin's lymphoma can be treated by limited cycles of chemotherapy with minimal radiotherapy to achieve cure. In contrast, highrisk, classical Hodgkin's lymphoma treatment relies on intense chemotherapy regimes with diverse agents, in combination with radiotherapy [40] . Disease-free survival rates of over 90% have been achieved with recent protocols.
Conclusion
The care of children affected by head and neck malignancy must continue to be collaborative and multidisciplinary. Improved survival rates should lead to greater recognition and monitoring of the late psychosocial, physical, and economic impacts of a cancer diagnosis in childhood, including treatment-induced second primary tumors. The rarity of these tumors inevitably results in a paucity of high-level evidence to guide treatment. A combination of translational research from tumor biology studies, multicenter clinical trials, and smaller case series and case reports will continue to guide new advances in diagnosis and treatment.
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